GFACX
Price
$57.16
Change
-$3.41 (-5.63%)
Updated
Apr 3 closing price
Net Assets
279.82B
RGABX
Price
$59.54
Change
-$3.55 (-5.63%)
Updated
Apr 3 closing price
Net Assets
279.82B
Ad is loading...

GFACX vs RGABX

Header iconGFACX vs RGABX Comparison
Open Charts GFACX vs RGABXBanner chart's image
American Funds Growth Fund of Amer C
Price$57.16
Change-$3.41 (-5.63%)
VolumeN/A
Net Assets279.82B
American Funds Growth Fund of Amer R2
Price$59.54
Change-$3.55 (-5.63%)
VolumeN/A
Net Assets279.82B
GFACX vs RGABX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. RGABX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and RGABX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX (280B) and RGABX (280B) have equal amount of cash in the bank . GFACX (0.00) and RGABX (0.00) have matching dividends . GFACX was incepted earlier than RGABX: GFACX (24 years) vs RGABX (23 years). RGABX (1.39) and GFACX (1.36) have similar cost to investors . GFACX (25.00) and RGABX (25.00) have comparable annual turnover. GFACX (250) and RGABX (250) have matching initial minimum investment requirements. RGABX annual gain was more profitable for investors over the last year : -1.42 vs. GFACX (-1.75). RGABX (61.44) and GFACX (59.73) have equivalent 5 years return.
GFACXRGABXGFACX / RGABX
Total Expense Ratio1.361.3998%
Annual Report Gross Expense Ratio1.361.3998%
Fund Existence24 years23 years-
Gain YTD-5.003-5.014100%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets280B280B100%
Annual Yield % from dividends0.000.00-
Returns for 1 year-1.75-1.42123%
Returns for 3 years0.631.3547%
Returns for 5 years59.7361.4497%
Returns for 10 years44.4647.5893%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLY9.54-0.41
-4.12%
Oatly Group AB
INDP0.47-0.03
-5.24%
Indaptus Therapeutics
VTRS8.16-0.50
-5.77%
Viatris
GDRX4.29-0.28
-6.13%
GoodRx Holdings
KOD2.40-0.27
-10.11%
Kodiak Sciences